Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 1 12Phase 3 5Phase NA 2Phase 1/2 2Phase 2/3 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 2Lung Neoplasms 1

Interventions

Standard of Care 177Blood Specimen Collection 137Exercise 123Educational Status 114Methods 109Interviews as Topic 106Practice Guidelines as Topic 105Surveys and Questionnaires 104Early Intervention, Educational 93Magnetic Resonance Spectroscopy 80Specimen Handling 78Radiosurgery 67Radiotherapy 56Palliative Care 48Biopsy 40Patient Navigation 37Control Groups 34Drug Therapy 32Therapeutics 31Surgical Procedures, Operative 31Resistance Training 31Diet Therapy 30Behavior Therapy 29Counseling 28Acupuncture Therapy 25Proton Therapy 24Exercise Test 24Nutrition Assessment 23Magnetic Resonance Imaging 23Radiation 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Erlotinib Hydrochloride × 1 year × Clear all
NCT02194738 2026-05-29

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

National Cancer Institute (NCI)

Phase NA Active not recruiting
8,300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00883480 2026-04-28

SLAT

Spanish Lung Cancer Group

Phase NA Completed
153 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡